Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by ANALIAS00on Nov 03, 2022 1:30am
125 Views
Post# 35068785

RE:RE:Shareholder outreach??

RE:RE:Shareholder outreach??Obviously the big ones did not rush on the market to buy shares and they did not spread the news that they were sitting on something big ready to explode. So not that convinced they were that impressed. THTX are like any other biotech. They will try their best to get results from their reseach and they will try their best to raise money to survive another 2 or 3 years. That is what they are paid for. And if they are Lucky, they may survive long enought to finally get results good enought to raise more money again. And so on. But yes, maybe, if they are lucky again, one Day, one Day....
Bucknelly21 wrote: He maybe was referring to the special calls all the big ones got


<< Previous
Bullboard Posts
Next >>